# Effectivity and Safety of Metronidazole 1% Cream in Rosacea Therapy

> **NCT05861310** · PHASE1 · UNKNOWN · sponsor: **Dr.dr.Irma Bernadette, SpKK (K)** · enrollment: 48 (estimated)

## Conditions studied

- Rosacea

## Interventions

- **DRUG:** Metronidazole 1% Cream,Top
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05861310
- **Lead sponsor:** Dr.dr.Irma Bernadette, SpKK (K)
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-05
- **Primary completion:** 2023-07
- **Final completion:** 2023-12
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2023-05-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05861310

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05861310, "Effectivity and Safety of Metronidazole 1% Cream in Rosacea Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05861310. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*